Table 6. Comparison between subjects who received survivor clinic assistance versus subjects who did not receive assistance (in subjects with at least 5-year post-treatment follow-up).
| ASSISTANCE (N=76) |
NO ASSISTANCE (N=119) |
||||
|---|---|---|---|---|---|
| Median | Range | Median | Range | p-value | |
| Age at Diagnosis (yrs) | 6.0 | 0.5-19.5 | 9.0 | 0-20.0 | 0.2688 |
| N | % | N | % | p-value | |
| Irregular Periods at last follow-up | 13 | 17 | 10 | 8 | 0.1428 |
| Menearche before Diagnosis | 17 | 22 | 38 | 32 | 0.0609 |
| Ammenorrhea >12 months post trt | 9 | 12 | 5 | 4 | 0.0715 |
| FSH level ≥10 (more than 10) | 8 | 11 | 9 | 8 | 0.6490 |
| Radiation Therapy | 26 | 34 | 22 | 18 | 0.0178 |
| Chemotherapy | 75 | 99 | 75 | 63 | <0.001 |
| Bone Marrow Transplant | 9 | 12 | 6 | 5 | 0.0822 |
| Alkylating Agent | 54 | 71 | 37 | 31 | <0.001 |
| Anthracycline Agent | 67 | 88 | 33 | 28 | <0.001 |